期刊文献+

Ⅳ期乳腺癌的外科治疗及TNM分期探讨 被引量:4

SURGICAL TREATMENT AND TNM STAGING INVESTIGATION ABOUT STAGE Ⅳ BREAST CARCINOMA
下载PDF
导出
摘要 目的 探讨Ⅳ期乳腺癌的分期与外科治疗方法。方法 对 38例Ⅳ期乳腺癌的外科治疗资料进行总结 ,并随访疗效。结果 对孤立的远处转移而局部病灶又能够切除的Ⅳ期乳腺癌患者采用根治性外科治疗 ,取得了较好效果 ;对有锁骨上淋巴结以外的广泛远处转移的Ⅳ期患者 ,以及局部肿瘤已无法切除的晚期乳腺癌 ,行姑息性的减瘤术 ,清除创面 ,改善了患者的生存质量和减少化疗负荷。结论 Ⅳ期乳腺癌的TNM分期应进一步分为Ⅳa 期及Ⅳb 期 ;Ⅳa期乳腺癌应选择根治性手术 ,Ⅳb 期应采用姑息性手术。 Objective To study the surgical therapy and staging investigation about stage Ⅳ breast carcinoma. Methods The clinical data of 38 patients with stage Ⅳ breast carcinoma were summarized, and the patients were followed up. Results The stage Ⅳ patients who had isolated metastasis and removable primary tumor were treated by radical surgery with good effect. On the other hand, the stage Ⅳ patients who had extensive metastasis and primary tumor unresectable were treated by palliative operation with the living quality of patients becoming better and chemotherapy load cutting down. Conclusion The stage Ⅳ patients should be divided into stage Ⅳ a and stage Ⅳ b. And the stage Ⅳ a patients should be treated by radical operation, and the stage Ⅳ b by palliative operation.
出处 《中国普外基础与临床杂志》 CAS 2001年第5期315-316,共2页 Chinese Journal of Bases and Clinics In General Surgery
关键词 Ⅳ期乳腺癌 外科手术 TNM分期 Breast carcinoma Surgical therapy TNM staging
  • 相关文献

参考文献1

二级参考文献10

  • 1李俊.乳腺癌的新辅助化疗[J].国外医学(外科学分册),1997,24(1):29-31. 被引量:16
  • 2Wang HC, Lo SS. Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer, Semin Surg Oncol,1996:12:59.
  • 3Hayward JL, Rubens RD. Assessment of response to therapy in advanced breast cancer. Br J Cancer,1977,35,292.
  • 4Hunt KK, Ames FC, Singletary SE, et al. Locally advanced noninflammatory breast cancer, Surg Clin North Am, 1996,76:393.
  • 5Pinedo HM, Honkoop AH, Hoekman K. et al. Improved disease-free survival (DFS) of patients with locally advanced breast cancer(LABC) using prolonged dose intensive neoadjuvant doxorubicin (A), cyclophosphamide (C) and GM-CSF(meeting abstract). Proc Am Meet Am Soc Clin Oncol,1996,15 ; A88.
  • 6Lind MJ,Grambreii L, Cantwell BMJ, et al. The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer. Br J Cancer, 1995,71:610.
  • 7Olson JE. Management of nonresectable loeally advanced(stge I ) breast caneer;An ECOG trial. Breast Cancer Res Treat,1986,8:109.
  • 8Scholl SM, Fourquet A, Asselain B, et al, Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery ; Preliminary results of a randomized trial:S6. Eur J Cancer,1994,30:645.
  • 9Mauriac L, Durand M, Avril A, et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumor larger than 3 cm. Ann Oncol,1992,2:347.
  • 10Fisher B, Gunduz N, Saffer EA. et al. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res,1983,43:1488.

共引文献3

同被引文献19

  • 1黄秀英,张志学,李秀艳.彩色多普勒超声在乳腺癌TNM分期中的应用[J].实用医学影像杂志,2004,5(4):220-221. 被引量:3
  • 2李向东.C-erbB-2、ER和PR在乳腺癌中的表达与预后意义[J].现代肿瘤医学,2006,14(3):289-290. 被引量:31
  • 3胡永生 主编.现代乳腺影像诊断学[M].北京:科学出版社,2001.25-26.
  • 4Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis[J]. Am J Public Health, 2006,96 (12) :2173 - 2178.
  • 5Pascal B, Sylvie R, Colette C, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features[J]. Int J Caneer, 1995,62 (3) : 138 - 144.
  • 6Maureen C, Helena R, Kirby B, et al. Younger women with breast carcinoma have a poorer prognosis the Han older women [ J ]. Caneer, 1996,77 (3) :97 - 103.
  • 7Rapiti E, Fioretta G, Verkooijen HM, et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001 [J]. Eur J Caneer,2005,41 (10).1446 - 1452.
  • 8Foo CS, Su D, Chong CK, et al. Breast cancer in young Asian women : study on survival [ J ]. ANZ J Surg, 2005, 75(7) :566 -572.
  • 9Hayes DF, Yamauchi H, Broadwater G, et al. Circulating HER-2/c-erbB-2/c-neu ( HER-2 ) extra cellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662 [J]. Clin Cancer Res,2001,7(9) :2703 - 2711.
  • 10Yang JQ, Chen L, Xing TY. Relationship of oncogene C- erbB-2 expression to ER, PR and PS2 in breast cancer and its prognostic significance [ J ]. Siehuan Da Xue Xue Bao Yi Xue Ban ,2004,35 ( 3 ) : 334 - 336.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部